Known targets — ChEMBL curated mechanism
SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A
The experimentally established mechanism targets of Benoxinate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A known ✓ | P35498 | 5/20 | 1.00 |
| ▸ | SCN2A known ✓ | Q99250 | 5/20 | 1.00 |
| ▸ | SCN3A known ✓ | Q9NY46 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | RAD52 | P43351 | 1/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.72 |
| ▸ | MAOA | P21397 | 3/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.72 |
| ▸ | HTR3A | P46098 | 3/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benoxinate SCHEMBL30849863 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Benoxinate SCHEMBL212440 | 0.99 | RAD52 (1.00) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Benoxinate SCHEMBL1649661 | 0.99 | RAD52 (1.00) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Benoxinate SCHEMBL15532182 | 0.98 | CYP2D6 (0.95) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Benoxinate SCHEMBL16633604 | 0.95 | CYP2D6 (0.91) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Benoxinate SCHEMBL18740891 | 0.94 | CYP2D6 (0.89) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| SCHEMBL13439964 | 0.94 | CYP2D6 (0.89) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| Betoxycaine SCHEMBL6898673 | 0.91 | CYP2D6 (0.82) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| SCHEMBL10533525 | 0.91 | CYP2D6 (0.83) | CYP2D6CYP1A2SCN1ASCN2ASCN3A | |
| SCHEMBL14304165 | 0.90 | CYP2D6 (0.82) | CYP2D6CYP1A2SCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7401 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743122-A1 | THERAPEUTIC SEALANTS BASED UPON DRUG CONJUGATES | The Johns Hopkins University (US) | 2026-05-20 | — | — | EP | claimed |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4436552-B1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B V (NL) | 2026-02-04 | — | — | EP | claimed |
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250319025-A9 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-16 | — | — | US | claimed |
| US-20250302792-A1 | ACTIVE SUBSTANCES FOR MEDICAL USE | INFLAMED PHARMA GMBH (DE) | 2025-10-02 | — | — | US | claimed |
| US-20250285560-A1 | AR MARKER FOR INJECTION | NOBLE INTERNATIONAL, LLC | 2025-09-11 | — | — | US | claimed |
| US-20250255963-A1 | FORMULATIONS FOR EYE TREATMENTS | AVEDRO INC (US) | 2025-08-14 | — | — | US | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| EP-4578441-A1 | TREATMENT OF LOCALIZED PAIN | PlantTec Medical GmbH (DE) | 2025-07-02 | — | — | EP | claimed |
| US-4952212-A | Ocular treatment | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-08-28 | — | — | US | claimed |
| EP-0224352-A1 | Ocular treatment | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-06-03 | — | — | EP | claimed |
| US-4636387-A | MODIFIED WITH 2-AMINOPYRIDINE, BENOXINATE, NAEPAINE AND PHENACAINE | RESEARCH CORPORATION (US) | 1987-01-13 | — | — | US | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474751-A | SUSTAINED RELEASE USING AN ALKYLENEDIAMINE-MODIFIED ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0002426-A1 | Antiperspirant | Playtex-Wallco Aktiebolag (SE) | 1979-06-13 | — | — | EP | claimed |
| US-4105760-A | Local anaesthetic salts of chondroitinsulfate compounds | SZEJTLI JOZSEF | 1978-08-08 | — | — | US | claimed |
| US-4041174-A | INJECTING AN ESTER LOCAL ANESTHETIC | ROM-AMER PHARMACEUTICALS, LTD. (US) | 1977-08-09 | — | — | US | claimed |
| US-4029794-A | SAXITOXIN | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1977-06-14 | — | — | US | claimed |
| US-4022899-A | TETRODOXIN, DESOXYTETRODOXIN, AMINOALKYL BENZOATE | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1977-05-10 | — | — | US | claimed |